BackAcrivon Therapeutics Overview

Acrivon Therapeutics Operating Income

Operating Income for ACRV.

Quarterly Operating Income

$-19902000.00
8.12% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-82354000.00
11.63% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)